The independent source for health policy research, polling, and news.
701 - 720 of 1,299 Results
Katie West, an American health researcher who has lived in Germany the past three years, hasnât mastered the language and misses her family. But not having to worry about the cost of her lifesaving medication makes it OK.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you donât have to.
Manufacturers of lucrative drugs say theyâre offering discounts off the high sticker prices â but taxpayers footing the big bills might never know what the state is paying or if itâs getting a good deal.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you donât have to.
House Democrats start legislative work on House Speaker Nancy Pelosiâs prescription drug pricing bill; health is again a featured player in the Democratic presidential candidate debate; and courts around the country hold up President Donald Trumpâs health agenda. This week, Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of Politico join KHNâs Julie Rovner to discuss these issues and more. Plus, for âextra credit,â the panelists recommend their favorite health stories of the week.
The topic, which polls show is top of mind among voters, kept returning throughout the fourth debate of Democratic presidential candidates.
The Democratic presidential candidates have hit hard on health care, but generally the debates have centered on what kind of system candidates propose. The candidatesâ ideas on many other issues, such as mental health and gun safety, have attracted much less attention.
Pharmaceutical companies raised the wholesale cost of their drugs by a median of nearly 26% from 2017 to early 2019, according to Californiaâs first-ever report stemming from a new drug price transparency law. Prices for generic drugs rose nearly 38% during that time.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
For more than a decade, customers used the online plan finder to compare dozens of policies. Yet after a redesign of the website, the search results no longer list which plan offers a customer the best value. Federal officials say it will be fixed before enrollment begins next week.
Unlike in the U.S., health insurance in Germany doesnât cover birth control. German health advocates say that causes health problems â but change is unlikely.
President Donald Trump, dogged by an impeachment inquiry, tries to change the subject by unveiling an executive order aimed at expanding the role of private Medicare health plans. The Trump administration also launched an effort this week to expand âwellnessâ programs aimed at getting people with insurance to practice better health habits â even though research has shown the efforts donât generally improve health or save money. This week, Alice Miranda Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call join KHNâs Julie Rovner to discuss these issues and more.
The American Academy of Pediatrics is out with new guidelines on ADHD that some hoped would boost the role of behavioral interventions before medications. But the AAP stuck by its recommendation that children 6 and older should be given medicine combined with therapy after diagnosis.
Washington is abuzz with impeachment talk, but what impact would such a move have on congressional action on prescription drug prices and surprise bills? Also, a study out this week shows that health insurance costs for both employers and workers continue to rise. This week, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHNâs Julie Rovner to discuss these issues and more.
Naltrexone, commonly used for opioid and alcohol use disorders, may also help patients with chronic pain â when prescribed in low doses. But few doctors or patients seem to know about it.
The reasons behind one particular shortage of a therapy known as IVIG are complicated, stemming from increased demand and the medicationâs long production window.
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.
Tennessee wants to convert its Medicaid program to a block grant. But is its plan legal? Meanwhile, Congress continues to struggle with legislation to rein in prescription drug prices and surprise medical bills. This week, Anna Edney of Bloomberg News, Jennifer Haberkorn of the Los Angeles Times and Kimberly Leonard of the Washington Examiner join KHNâs Julie Rovner to discuss these issues and more. Rovner also interviews Dr. Marty Makary, author of the new book âThe Price We Payâ about why health care costs so much.
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
Illegal medications, sold in immigrant communities around the United States, can cause serious harm to consumers, authorities say. Law enforcement officers are cracking down, but some think more must be done.
© 2026 KFF